Amylin Pharmaceuticals

AMLN

Amylin is a biopharmaceutical company which engages in the discovery, development, and commercialization of medicines for diabetes, obesity, among other diseases.

AMLN is Unavailable

Amylin Pharmaceuticals has been flagged in our system as a defunct equity. Most likely, the company has gone private or the stock has been delisted. If you feel this is an error, please contact Piqqem Support

User takes
Tweets

Have something to say?

Register for Piqqem
and give us your take on Amylin Pharmaceuticals

Name	Ticker	Closing Prices (1 year)	My Piqq
Amylin Pharmaceuticals	AMLN	31.0	Defunct
Alkermes, Inc.	ALKS	31.04
Amgen, Inc.	AMGN	102.18
DexCom	DXCM	21.24
Eli Lilly & Co.	LLY	55.02
Mannkind Corp.	MNKD	5.31
Nektar Therapeutics	NKTR	9.73
Novo Nordisk A S	NVO	171.68